Coca-Cola’s interest in marijuana has fizzled out

It’s time to cross one potential cannabis partner off your list.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This article was originally published on Fool.com

The marijuana industry has truly budded in 2018. It’s been a year in which we’ve witnessed numerous marijuana firsts, including the most important event of all: Canada becoming the first industrialized country in the world to legalize recreational marijuana. The cannabis industry has gained legitimacy this year, and the expectation is that billions of dollars will begin flowing into legal channels through the remainder of this year and beyond.

Investors have clearly taken note of this opportunity to make some green of their own. Although it’s been an exceptionally volatile industry, which is to be expected given that there’s no precedent for an industrialized country legalizing adult-use weed, marijuana stocks have been the top-performing industry since the beginning of 2016.

Dried cannabis buds next to a piece of paper that says "yes," lying atop dozens of miniature Canadian flags.

IMAGE SOURCE: GETTY IMAGES.

Brand-name businesses turn to cannabis for growth

Of course, it isn’t just investors that’ve taken notice. Brand-name companies in the beverage, tobacco, and pharmaceutical industries have been looking for ways to boost their own potentially stagnant sales growth by partnering or investing in the cannabis industry.

On Aug. 1, Molson Coors Brewing Co. announced a joint venture with Quebec-based HEXO Corp.  to develop a line of cannabidiol-infused beverages. Cannabidiol, or CBD, is the nonpsychoactive cannabinoid best known for its perceived medical benefits. Molson Coors has seen years of declining sales and market share in Canada, and HEXO, though possibly a top-10 producer by aggregate volume at 108,000 kilograms in estimated peak yield, is looking to make a name for itself in an otherwise crowded field of growers. Then again, both Molson Coors and HEXO will need to be patient, as CBD-infused beverages, along with vapes, concentrates, and edibles, aren’t yet legal in Canada.

Constellation Brands also bit on the cannabis craze — and more than once, might I add. Just two weeks after Molson Coors forged its deal with HEXO, the Corona and Modelo beer maker announced its intent to invest $3.8 billion in Canopy Growth Corporation. This marked the company’s third investment in Canopy Growth and should bring its stake up to 38%. In addition to product development, which will almost certainly include CBD-infused beverages, Constellation Brands will help Canopy Growth enter new foreign markets.

Pharmaceutical companies have gotten in on the action, too. Novartis‘ generic-drug subsidiary Sandoz announced a strategic partnership with Tilray back in March to sell co-branded products in pharmacies and hospitals throughout Canada, as well as to collaborate on research and development of cannabinoid-based products.

In other words, brand-name companies see plenty of potential in the burgeoning pot industry.

Well… most brand-name companies, at least.

Two young adults tapping their Coca-Cola glass bottles together while enjoying each other's company outside.

IMAGE SOURCE: COCA-COLA.

Coca-Cola’s interest in CBD-infused beverages fizzles out

On Tuesday, global beverage powerhouse Coca-Cola (NYSE:KO) reported its third-quarter operating results, and among the many things that management touched on was the company’s interest in the cannabis space.

For those who may not recall, Coca-Cola made headlines in September when BNN Bloomberg reported that the company was in talks with Aurora Cannabis about potentially teaming up and/or making an investment. A deal would certainly have seemed to make sense. Aurora Cannabis is projected to be the largest producer by annual yield — 570,000 kilograms, per the company, although this should head higher with its ongoing acquisition of ICC Labs — and has its footprint in more than a dozen foreign countries. In short, Aurora Cannabis appeared to have an inside track to snagging a partner of Coca-Cola’s caliber.

But Coca-Cola closed that door this past Tuesday. During the company’s conference call, CEO James Quincey told analysts that “We’ve got no plans in the cannabis or marijuana or CBD space at this moment. I don’t see that as something that we’ll be getting into anytime soon. It’s just not something we’re interested in.”

Ouch! Not only did Coca-Cola step on near-term rumors of partnering up with Aurora Cannabis, but it poured water on what had been a red-hot industry. 

A cannabis-infused beverage with a pot leaf sitting atop a bed of carbonated bubbles.

IMAGE SOURCE: GETTY IMAGES.

Here’s why Coca-Cola suddenly has cold feet

So, why the sudden about-face from Coca-Cola?

One possible reason is the time it’ll take for the industry to get up to speed. It took mere hours for some regions of Canada to run into product shortages (looking at you, Manitoba), which means it could be multiple quarters before pot companies would be able to devote their attention to CBD-infused beverages. If marijuana companies can’t produce what a company like Coca-Cola needs, there’s little incentive to make a deal.

Second, Coca-Cola may not be enamored with the Canadian market. Even though legalization is expected to bring in upwards of $5 billion in added annual sales, there are other markets that would be considerably larger if cannabis became legal in them. Perhaps if the U.S. were to change its tune on cannabis, Coca-Cola would dip its toes in the pond, so to speak. Until that time, there may not be enough financial incentive to get Coca-Cola involved.

Last, there’s also the possibility that Coke felt marijuana stocks were grossly overvalued. After all, history has shown that all next-big-thing ideas have eventually deflated prior to industry maturation over the past quarter century. If Coca-Cola were to invest in Aurora Cannabis, it probably would have had to pay a premium. Had it paid, say, a 20% premium in mid-September, it’d be down nearly 50% on its investment.

Whatever the reason(s) may be, it’s time to cross Coca-Cola off your list as a possible investor or partner in the cannabis space.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Sean Williams, the original author of this article, has no position in any of the stocks mentioned. The Motley Fool US owns shares of Molson Coors Brewing. The Motley Fool US recommends Constellation Brands and Hexo. The Motley Fool has a disclosure policy.

 

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »